{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:45:23Z","timestamp":1791985523468,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"DOI":"10.1007\/s10067-026-08462-8","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:51:24Z","timestamp":1791982284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Osteoporosis and fracture severity as independent risk factors for osteonecrosis of the jaw in rheumatoid arthritis: a TriNetX cohort study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4926-3528","authenticated-orcid":false,"given":"Hiroko","family":"Nagafuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1802-5092","authenticated-orcid":false,"given":"Takayasu","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4359-9987","authenticated-orcid":false,"given":"Kimito","family":"Kawahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"8462_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/annrheumdis-2020-218758","volume":"80","author":"S Abtahi","year":"2021","unstructured":"Abtahi S, Driessen JHM, Burden AM et al (2021) Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 80:423\u2013431. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218758","journal-title":"Ann Rheum Dis"},{"key":"8462_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41584-024-01120-w","volume":"20","author":"F Buttgereit","year":"2024","unstructured":"Buttgereit F, Palmowski A, Bond M, Adami G, Dejaco C (2024) Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases. Nat Rev Rheumatol 20:417\u2013431. https:\/\/doi.org\/10.1038\/s41584-024-01120-w","journal-title":"Nat Rev Rheumatol"},{"key":"8462_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/odi.12490","volume":"22","author":"O Di Fede","year":"2016","unstructured":"Di Fede O, Bedogni A, Giancola F et al (2016) BRONJ in patients with rheumatoid arthritis: a multicenter case series. Oral Dis 22:543\u2013548. https:\/\/doi.org\/10.1111\/odi.12490","journal-title":"Oral Dis"},{"key":"8462_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00774-016-0763-x","volume":"35","author":"T Furuya","year":"2017","unstructured":"Furuya T, Maeda S, Momohara S, Taniguchi A, Yamanaka H (2017) Dental treatments, tooth extractions, and osteonecrosis of the jaw in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study. Journal of Bone and Mineral Metabolism 35:344\u2013350. https:\/\/doi.org\/10.1007\/s00774-016-0763-x","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"8462_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/1060028016649368","volume":"50","author":"RS Bejhed","year":"2016","unstructured":"Bejhed RS, Kharazmi M, Hallberg P (2016) Identification of risk factors for bisphosphonate-associated atypical femoral fractures and osteonecrosis of the jaw in a pharmacovigilance database. Ann Pharmacother 50:616\u2013624. https:\/\/doi.org\/10.1177\/1060028016649368","journal-title":"Ann Pharmacother"},{"key":"8462_CR6","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1007\/s10067-026-08130-x","volume":"45","author":"H Nagafuchi","year":"2026","unstructured":"Nagafuchi H, Ando T, Goto Y, Kawahata K (2026) Clinical analysis of osteonecrosis of the jaw in patients with rheumatoid arthritis: risk factors and oral health implications. Clin Rheumatol 45:3227\u20133233. https:\/\/doi.org\/10.1007\/s10067-026-08130-x","journal-title":"Clin Rheumatol"},{"key":"8462_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/BOR.0000000000000885","volume":"34","author":"M Lorentzon","year":"2022","unstructured":"Lorentzon M, Abrahamsen B (2022) Osteoporosis epidemiology using international cohorts. Curr Opin Rheumatol 34:280\u2013288. https:\/\/doi.org\/10.1097\/BOR.0000000000000885","journal-title":"Curr Opin Rheumatol"},{"key":"8462_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/art.43332","volume":"78","author":"PC Shih","year":"2026","unstructured":"Shih PC, Wang SI, Wei JCC (2026) Association of abatacept with lower mortality risk compared to rituximab in rheumatoid arthritis-associated interstitial lung disease: an emulated target trial. Arthritis Rheumatol 78:592\u2013602. https:\/\/doi.org\/10.1002\/art.43332","journal-title":"Arthritis Rheumatol"},{"key":"8462_CR9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M et al (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"8462_CR10","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2147\/CLEP.S325080","volume":"13","author":"LAS Stevens","year":"2021","unstructured":"Stevens LAS, Spangler L, Yochum L, Ding Y, Wang FT (2021) Assessment of a claims-based ICD-9 and ICD-10 medication-related osteonecrosis of the jaw algorithm in the United States. Clin Epidemiol 13:1019\u20131026. https:\/\/doi.org\/10.2147\/CLEP.S325080","journal-title":"Clin Epidemiol"},{"key":"8462_CR11","doi-asserted-by":"publisher","first-page":"410","DOI":"10.36740\/WLek\/196443","volume":"78","author":"MA Datsenko","year":"2025","unstructured":"Datsenko MA, Bandrivsky YL, Perebyjnis PP (2025) The impact of systemic osteoporosis on the bone structure of the alveolar processes. Wiad Lek 78:410\u2013414. https:\/\/doi.org\/10.36740\/WLek\/196443","journal-title":"Wiad Lek"},{"key":"8462_CR12","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1001\/archinte.165.15.1762","volume":"165","author":"MR McClung","year":"2005","unstructured":"McClung MR, San Martin J, Miller PD, Civitelli R, Bandeira F, Omizo M, Donley DW, Dalsky GP, Eriksen EF (2005) Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med 165:1762\u20131768. https:\/\/doi.org\/10.1001\/archinte.165.15.1762","journal-title":"Arch Intern Med"},{"key":"8462_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10785","volume":"7","author":"S Tetradis","year":"2023","unstructured":"Tetradis S, Allen MR, Ruggiero SL (2023) Pathophysiology of medication-related osteonecrosis of the jaw \u2013 a minireview. JBMR Plus 7:e10785. https:\/\/doi.org\/10.1002\/jbm4.10785","journal-title":"JBMR Plus"},{"key":"8462_CR14","first-page":"488","volume":"35","author":"JA Eisman","year":"2008","unstructured":"Eisman JA, Civitelli R, Adami S et al (2008) Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. J Rheumatol 35:488\u2013497","journal-title":"J Rheumatol"},{"key":"8462_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.eprac.2025.02.016","volume":"31","author":"DS Ali","year":"2025","unstructured":"Ali DS, Khan AA, Morrison A et al (2025) Antiresorptive therapy to reduce fracture risk and effects on dental implant outcomes in patients with osteoporosis: a systematic review and Osteonecrosis of the Jaw Taskforce consensus statement. Endocr Pract 31:686\u2013698. https:\/\/doi.org\/10.1016\/j.eprac.2025.02.016","journal-title":"Endocr Pract"},{"key":"8462_CR16","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/jbmr\/zjae119","volume":"39","author":"F Cosman","year":"2024","unstructured":"Cosman F, Lewiecki EM, Eastell R et al (2024) Goal-directed osteoporosis treatment: ASBMR\/BHOF task force position statement 2024. J Bone Miner Res 39:1393\u20131405. https:\/\/doi.org\/10.1093\/jbmr\/zjae119","journal-title":"J Bone Miner Res"},{"key":"8462_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","volume":"35","author":"T Yoneda","year":"2017","unstructured":"Japanese Allied Committee on Osteonecrosis of the Jaw, Yoneda T, Hagino H et al (2017) Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese allied committee on osteonecrosis of the jaw. J Bone Miner Metab 35:6\u201319. https:\/\/doi.org\/10.1007\/s00774-016-0810-7","journal-title":"J Bone Miner Metab"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08462-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08462-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08462-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:51:24Z","timestamp":1791982284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08462-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":17,"alternative-id":["8462"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08462-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"19 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used de-identified data from the TriNetX database and was exempt from institutional review board approval; the requirement for informed consent was waived by the institutional review board of St. Marianna University School of Medicine.","order":1,"name":"Ethics","label":"Ethics approval and consent","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}